Pleural macrophages differentially alter pleural mesothelial cell glycosaminoglycan production

Experimental Lung Research

Volumn 22, Issue 1, 1996, Pages 101-111

  Baumann, Michael H ^a,c   Strange, Charlie ^a   Sahn, Steven A ^a   Kinasewitz, Gary T ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

glycosaminoglycan; inflammation; macrophage; pleura

Indexed keywords

GLYCOSAMINOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL INJURY; GLYCOSAMINOGLYCAN METABOLISM; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PLEURA; PLEURA DISEASE; PLEURISY; PRIORITY JOURNAL; RABBIT; RAT;

EID: 0030033645     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.3109/01902149609074020     Document Type: Article

References (32)

1. Strange C, Tomlinson JR, Wilson C, Harley R, Miller KS, Sahn SA. The histology of pleural injury with tetracytline, empyema, and carrageenan. Exp Mol Pathol. 1989;51:205-219.
2. Baumann MH, Strange C, Heinrich K, Sahn SA. Tetracycline stimulated macrophages increase fibroblast growth and collagen production: a possible role intetracycline pleurodesis. Chest. 1989;96:219S.
3. Baumann MH, Heinrich K, Sahn SA, Strange C. Pleural macrophages differentially alter mesothelial cell growth and collagen production.Inflammation. 1993;17:1-12.
4. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
5. Muir H. Structure, biology, and pathology of proteoglycans: the coming of age of proteoglycans. Biochem Soc Trans. 1990;18:787-788.
6. Kinasewitz GT, Baumann AP, Schuler PM, Gullat TJ. Cytokine modulation of glycosaminoglycan production by human pleural mesothelial cells. Am Rev Respir Dis. 1989;139:A408.
7. Arai H, Endo M, Yokosawa A, Sato H, Motomiya M, Konno K. On acid glycosaminoglycans (mucopolysaccharides) in pleural effusions. Am Rev Respir Dis. 1975;111:37-42.
8. Wusteman FS, Gold C, Wagner JC. Glycosaminoglycan and calcification in the lesions of progressive massive fibrosis and in pleural placques. Am Rev Respir Dis. 1972;106:116-118.
9. Arai M, Endo M, Sasai Y, et al. Histochemical demonstration of hyaluronic acid in a case of pleural mesothelioma. Am Rev Respir Dis. 1975;111:699-702.
10. Bray B, Willhite M, Rodriguez L, Godman GC, Turino GM. Glycosaminoglycans (GAGs) synthesized by mesothelial cells (mc). FASEB J. 1988;2(5):A1589.
11. Schuler PM, Kinasewitz GT, Owens MW, Baumann AP. Glycosaminoglycan production by human mesothelial cells. Clin Res. 1988;36:45A.
12. Koski IR, Poplack DG, Blaese RM. A nonspecific esterase stain for the identification of monocytes and macrophages. In: Bloom BR, David JR, eds. In Vitro Methods in Cell-Mediated and Tumor Immunity. New York: Academic; 1976:359-360.
13. Sahn SA, Potts DE. The effect of tracycline on rabbit pleura. Am Rev Respir Dis. 1978;117:493-499.
14. Kittlick PD, Engelmann D. The glycosaminoglycans in cultures of stimulated rat peritoneal macrophages. Exp Toxicol Pathol. 1992;44:401-413.
15. De-Jian C, Dubaybo BA, Durr RA, Thet LA. Effect of subcellular matrix onglycosaminoglycan synthesis by human fibroblasts. J Appl Physiol. 1987;63:2181-2188.
16. Elais JA, Krol RC, Freundlich B, Sampson PM. Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin. J Clin Invest. 1988;81:324-333.
17. Arruffo A, Stamenkovic I, Mlnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990;61:1303-1313.
18. Hallgren R, Smuelsson T, Laurent TC, Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989;139:682-687.
19. Hallgren R, Eclund A, Engstrom-Laurent A, Schmekel B. Hyaluronate in broncoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Br Med J. 1985;290:1778-1781.
20. Bjermer L, Engstrom-Laurent A, Lundgren R, Rosenhall I, Hallgren R. Hyaluronate and type III procollagen peptide concentrations in bronchoalveolar lavage fluid as markers of disease activity in farmer's lung. Br Med J. 1987;295:803-806.
21. Blaschke E, Eklund A, Hernbrand R. Extracellular matrix components in broncholalveolar lavage fluid in sarcoidosis and their relationship to signs of alveolitis. Am Rev Respir Dis. 1990;141:1020-1025.
22. Masuda H, Ozeki T, Takazono I, Tanaka Y. Tissue content of glycosaminoglycans in the diffuse idiopathic interstitial fibrosis patient. Am J Med Sci. 1988;295:507-512.
23. Cantor JO, Osman M, Cerreta JM, Mandl I, Turrino GM. Glycosaminoglycan synthesis in explants derived from bleomycin-treated fibrotic hamster lungs. Proc Soc Exp Biol Med. 1983;173:362-366.
24. Cantor JO, Bray BA, Ryan SF, Mandl I, Turrino GM. Glycosaminoglycan and collagen synthesis in N-nitrosos-methylurethan induced pulmonary fibrosis. Proc Soc Exp Biol Med. 1980;164:1-8.
25. Cantor JO, Cerreta JM, Osman M, Mott SH, Mandl I, Turino GM. Glycosaminoglycan synthesis in bleomycin-induced pulmonary fibrosis: biochemistry and autoradiography. Proc Soc Exp Biol Med. 1983;171:172-181.
26. Håkansson L, Hällgren R, Venge P. Regulation of granulocyte function by hyaluronic acid: in vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest. 1980;66:298-305.
27. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
28. Shimokata K, Saka H, Murate T, Hasegawa Y, Hasegawa T. Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest. 1991;99:1103-1107.
29. Barnes PF, Fong SJ, Brennan FJ, Twomey PE, Maxumder A, Modlin RL. Local production of tumor necrosis factor and IFN-Á in tuberculous pleuritis. J Immunol. 1990;145:149-154.
30. Sahn SA. The pleura. Am Rev Respir Dis. 1988;138:184-234.
31. O'Dell SL, Kinasewitz, GT. Heparin inhibits human pleural mesothelial cell proliferation in vitro. Am J Respir Crit Care Med. 1995;149:A846.
32. Strange C, Baumann MH, Sahn SA, Idell SA. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Respir Crit Care Med. 1995;151:508-515.